Literature DB >> 2060558

Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.

B Baggio1, G Gambaro, G Marzaro, F Marchini, A Borsatti, G Crepaldi.   

Abstract

Oral administration of mixture of extractive glycosaminoglycans to a group of renal stone formers led to a significant decrease in oxalate self-exchange and in erythrocytes membrane protein phosphorylation traits that are abnormal in the majority of patients with idiopathic calcium nephrolithiasis. The action of glycosaminoglycans at the cellular level is probably due to their modulating activity on certain membrane protein kinases. The proven effect of the glycosaminoglycans opens a new pharmacological approach to the prevention of recurrent nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060558     DOI: 10.1007/bf00315202

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.

Authors:  R W Norman; D S Scurr; W G Robertson; M Peacock
Journal:  Clin Sci (Lond)       Date:  1985-03       Impact factor: 6.124

2.  Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycosaminoglycan.

Authors:  B Radhakrishnamurthy; C Sharma; R R Bhandaru; G S Berenson; L Stanzani; R Mastacchi
Journal:  Atherosclerosis       Date:  1986-05       Impact factor: 5.162

3.  Oral heparin results in the appearance of heparin fragments in the plasma of rats.

Authors:  A K Larsen; D P Lund; R Langer; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Chim Acta       Date:  1973-01-10       Impact factor: 3.786

5.  Erythrocyte membrane protein phosphorylation in urolithiasis.

Authors:  B Baggio; G Clari; G Marzaro; G Gambaro; A Borsatti; V Moret
Journal:  Contrib Nephrol       Date:  1987       Impact factor: 1.580

6.  Kinetic behaviour of human erythrocyte casein kinases. Effect of 2, 3-bisphosphoglycerate and heparin.

Authors:  G Clari; S Ferrari
Journal:  Ital J Biochem       Date:  1983 May-Jun

7.  An inheritable anomaly of red-cell oxalate transport in "primary" calcium nephrolithiasis correctable with diuretics.

Authors:  B Baggio; G Gambaro; F Marchini; E Cicerello; R Tenconi; M Clementi; A Borsatti
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

8.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

9.  Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.

Authors:  D J Kok; S E Papapoulos; L J Blomen; O L Bijvoet
Journal:  Kidney Int       Date:  1988-09       Impact factor: 10.612

10.  Calcium oxalate nephrolithiasis: an easy way to detect an imbalance between promoting and inhibiting factors.

Authors:  B Baggio; G Gambaro; O Oliva; S Favaro; A Borsatti
Journal:  Clin Chim Acta       Date:  1982-09-15       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.